These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 6084315)

  • 1. [Antibody-dependent and natural cellular cytotoxic reactions in rheumatic diseases].
    Aleksandrova EN; Zimin IuI; Nasonov EL
    Ter Arkh; 1984; 56(10):130-6. PubMed ID: 6084315
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
    Schrieber L; Maini RN
    Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation].
    Nasonov EL; Aleksandrova EN; Sura VV; Ivanova MM; Zimin IuI
    Ter Arkh; 1983; 55(7):32-7. PubMed ID: 6604958
    [No Abstract]   [Full Text] [Related]  

  • 4. The immunology of rheumatoid diseases.
    Koffler D
    Clin Symp; 1979; 31(4):1-36. PubMed ID: 45382
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
    Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
    Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunology and rheumatic diseases. History and current aspects].
    Bonomo L
    Recenti Prog Med; 1976 Dec; 61(6):741-8. PubMed ID: 1088188
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of reticuloendothelial system function in man using receptor-specific probes.
    Hamburger MI
    Neth J Med; 1984; 27(9):359-67. PubMed ID: 6239984
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of glucocorticosteroid and cytotoxic therapy on the natural cytotoxicity in rheumatic diseases].
    Aleksandrova EN; Nasonov EL
    Ter Arkh; 1985; 57(8):34-7. PubMed ID: 4071433
    [No Abstract]   [Full Text] [Related]  

  • 9. [Basic immunologic indices and their significance in the diagnosis of rheumatic diseases. II. Analysis of immunologic indices in individual rheumatic diseases].
    Timofeev VT
    Revmatologiia (Mosk); 1983; (4):48-54. PubMed ID: 6366975
    [No Abstract]   [Full Text] [Related]  

  • 10. [Circulating immune complexes and cellular cytotoxic reactions in Sjögren's syndrome].
    Nasonov EL; Vasil'ev VI; Aleksandrova EN; Nasonova SV; Timofeeva EB
    Ter Arkh; 1988; 60(4):13-6. PubMed ID: 2969150
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody-dependent cell-mediated cytotoxicity in selected autoimmune diseases.
    Feldmann JL; Becker MJ; Moutsopoulos H; Fye K; Blackman M; Epstein WV; Talal N
    J Clin Invest; 1976 Jul; 58(1):173-9. PubMed ID: 6490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.
    Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ
    Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukins, interferon and rheumatic disease.
    Talal N
    Clin Rheum Dis; 1985 Dec; 11(3):633-44. PubMed ID: 2416506
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural killer cells in connective tissue disorders.
    Sibbitt WL; Bankhurst AD
    Clin Rheum Dis; 1985 Dec; 11(3):507-21. PubMed ID: 3907953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease?
    Wenink MH; Leijten EFA; Cupedo T; Radstake TRDJ
    Arthritis Rheumatol; 2017 May; 69(5):885-897. PubMed ID: 28217945
    [No Abstract]   [Full Text] [Related]  

  • 16. [Increased numbers of large granular lymphocytes in the peripheral blood in selected inflammatory rheumatic diseases].
    Rovenský J; Tóth J; Rauová L; Lukác J; Zlnay D
    Vnitr Lek; 1991 Jun; 37(6):572-7. PubMed ID: 1897139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospects of the use of cyclosporin A in rheumatic diseases].
    Nasonov EL; Shtutman VZ; Nasonova VA
    Klin Med (Mosk); 1994; 72(5):12-9. PubMed ID: 7853807
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of immunodiffusion (RID) for quantiative evaluation of immunoglobulins in the rheumatological field].
    Biddau A; Bartoletti L; Doni A
    Reumatismo; 1968; 20(5):545-9. PubMed ID: 4186692
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of antibodies against intermediate filaments in rheumatoid polyarthritis, chronic inflammatory rheumatism and connective tissue diseases].
    Fabregas-Canales D; Meyer O; Haim T; Kuntz D
    Rev Rhum Mal Osteoartic; 1989 Jan; 56(1):45-50. PubMed ID: 2471252
    [No Abstract]   [Full Text] [Related]  

  • 20. T cells and the loss of immunologic tolerance in Sjögren's syndrome and systemic lupus erythematosus.
    Hoffman RW
    Arthritis Rheum; 2007 Oct; 56(10):3180-2. PubMed ID: 17907162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.